Kalisankar Bera

Title: Kalisankar Bera: Innovator in KAT6A Inhibitors

Introduction

Kalisankar Bera is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological pathways. His work is aimed at addressing critical health issues through innovative solutions.

Latest Patents

Kalisankar Bera holds a patent for acylsulfonamide KAT6A inhibitors. The present disclosure describes acylsulfonamide compounds of Formula (J), along with their pharmaceutically acceptable salts, compositions, methods, and uses. These compounds are believed to be therapeutically useful as KAT6A inhibitors, particularly in the treatment and/or prevention of diseases and disorders mediated by KAT6A in a subject. He has 1 patent to his name.

Career Highlights

Throughout his career, Kalisankar has worked with prominent companies in the pharmaceutical industry. He has been associated with Olema Pharmaceuticals, Inc. and Aurigene Oncology Limited. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Kalisankar has collaborated with several professionals in his field. Notable coworkers include Brian R. Hearn and David C. Myles, who have contributed to his research and development efforts.

Conclusion

Kalisankar Bera is a distinguished inventor whose work in KAT6A inhibitors showcases his commitment to advancing medical science. His innovative approach and collaborations highlight the importance of teamwork in achieving breakthroughs in healthcare.